4/A//SEC Filing
Johnson Shane Aaron 4/A
Accession 0001213900-22-073946
CIK 0001728328other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:36 PM ET
Size
6.4 KB
Accession
0001213900-22-073946
Insider Transaction Report
Form 4/AAmended
Johnson Shane Aaron
SVP, GM of BayMedica LLC
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-11-14−4,200→ 3,800 totalExercise: $2.78Exp: 2027-11-13→ Common shares (4,200 underlying)
Footnotes (3)
- [F1]The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
- [F2]On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
- [F3]On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,800 derivative securities of the Issuer.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001889332
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 7:36 PM ET
- Size
- 6.4 KB